Gene Query: MRPL3

Dataset Description Geneva Score
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 66.44
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 66.44
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 37.33
Total RNA-seq in ALL-SIL upon JQ1 inhibition 36.28
Co-transcriptional loading of RNA export factors shapes the human transcriptome 36.25
RNAseq of HEK293 cells after Chtop knockdown 36.25
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 32.17
Transcriptome analysis of U87 cells upon LINC00152 knockdown 31.86
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 31.16
RNA-seq analysis of BAP1-depleted uveal melanoma cells 31.07
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 29.76
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 29.76
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 25.23
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 25.23
FOXD3 is a novel tumor suppressor in lung cancer 25.14
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 23.8
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 23.34
Developmental stage specific chromosome architecture in human erythroid cells 23.34
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 23.11
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 23.11
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 20.97
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 20.86
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 20.86
Cleavage Factor Im as a key regulator of 3’ UTR length 20.75
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 20.66
hnRNP C is a key regulator of protein synthesis in mitosis 20.63
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 20.39
Genome wide expression change by RNF168 knocking down in NEC cells 20.34
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 20.29
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 20.23
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 20.23
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 19.96
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 19.76
The landscape of alternative splicing in aggressive prostate cancers 19.75
A549 cells and MSR-A549 cells 19.21
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 19.21
RNA-Seq with and without RNase treatment in PCa cell lines 19.06
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 18.53
Differetially expressed genes after hTR overexpression in U2OS cells 18.53
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 18.5
Transcriptome analysis upon C6orf203 silencing 18.18
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 18.12
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 17.59
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 17.57
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 17.51
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 17.37
Sensing self and nonself circular RNAs 17.31
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 17.04
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 17.03
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 16.94
Changes in human endometrial gland transcriptome over the window of implantation 16.89
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 16.88
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 16.78
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 16.69
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 16.49
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 16.42
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 16.0
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 16.0
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 15.41
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 15.38
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 15.38
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 15.23
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 15.2
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 15.2
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 15.09
3’ Uridylation Expands miRNA Target Repertoire 15.03
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 14.67
Differentially expressed vascular development genes for iPSC-ECs from CDI 14.65
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 14.54
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 14.33
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 14.27
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 14.19
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 14.11
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 14.04
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 13.96
ETV7 and interferon response 13.96
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 13.88
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 13.87
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 13.85
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 13.85
SLAM-seq for K562 endogenous mRNA decay 13.72
Paxillin regulates genomic networks in prostate cancer [LNCaP] 13.66
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 13.51
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 13.5
NRDE2 negatively regulates nuclear exosome functions 13.45
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 13.26
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 13.13
RNA-seq analysis of differentiating human erythroblasts 13.11
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 13.01
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 12.89
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 12.67
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 12.67
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 12.66
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 12.6
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 12.6
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 12.41
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 12.4
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 12.35
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 12.35
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 12.12
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 11.96
Mitochondrial dsRNA triggers antiviral signalling in humans 11.9
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 11.89
RNA sequencing of matched nephrectomy samples [RNA-seq] 11.89
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 11.87
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 11.85
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 11.81
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 11.76
RNA-seq analysis of RALD iPSCs after in vitro differentiation 11.7
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 11.69
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 11.66
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 11.66
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 11.62
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 11.6
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 11.4
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 11.22
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 11.12
G-quadruplex structures mark human regulatory chromatin 11.09
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 11.06
RNA seq with AML (NB4) cells upon FTO inhibition 10.97
Human cell line and subcutaneous tumor 10.96
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 10.9
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 10.9
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 10.86
Genome-wide discovery of human splicing branchpoints [RNAse] 10.84
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 10.75
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 10.75
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 10.73
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 10.71
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 10.7
RNA-seq of resting and activated CD4+ T cells +-JQ1 10.69
Transcriptome of activated human and mouse MAIT cells 10.68
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 10.62
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 10.62
Peptidomimetic blockade of MYB in acute myeloid leukemia 10.62
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 10.62
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 10.61
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 10.57
Identification of the role of polydom in neurofibromas 10.55
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 10.51
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 10.51
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 10.22
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 10.09
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 10.06
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 10.05
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 10.05
Identification of HOXB13 target genes responsive to BET inhibitors 10.04
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 10.03
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 10.01
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 9.96
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 9.96
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 9.9
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 9.88
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 9.88
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 9.86
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 9.84
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 9.81
Effect of Influenza virus infection on lncRNA expression in A549 cells 9.79
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 9.74
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 9.74
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 9.69
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 9.69
Trans-differentiation of human adult peripheral blood T cells into neurons 9.69
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 9.68
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 9.67
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 9.67
Rorc disruption in human FG pancreatic cancer cells 9.55
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 9.5
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 9.5
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 9.47
Crizotinib v. DMSO in SW480 cells 9.47
scRNASeq analysis of cycling cardiomyocytes 9.41
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 9.4
Primary Human B-cell Temporal Response to CD40L Stimulation 9.4
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 9.35
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 9.31
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 9.2
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 9.2
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 9.11
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 9.1
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 9.1
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 9.08
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 9.05
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 9.04
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 8.99
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 8.98
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 8.98
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 8.92
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 8.92
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.89
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 8.84
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 8.81
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 8.8
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 8.74
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 8.73
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 8.73
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 8.72
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 8.65
Effect of Hotair overexpression in human breast cancer cell lines 8.62
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 8.61
MARS Seq data from human cortical organoids 8.59
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 8.54
RNA sequencing of primary human platelets and in vitro cell lines 8.52
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 8.47
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 8.46
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 8.42
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 8.39
Regulation of protein translation during mitosis 8.39
CROP-Seq in Primary Human T Cells 8.36
Regulating Interleukin-2 activity with engineered receptor signaling clamps 8.33
A Unique Epigenomic Landscape Defines Human Erythropoiesis 8.3
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 8.3
Genome-wide discovery of human splicing branchpoints 8.24
MEIS1 regulates hematopoiesis in hPSCs 8.23
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 8.15
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 8.13
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 8.13
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 8.13
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 8.13
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 8.09
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 8.04
An optimization system for isolating and sequencing of single human colon cancer cells 8.03
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 8.01
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 8.01
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 8.01
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 7.99
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 7.97
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 7.96
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 7.95
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 7.95
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 7.95
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 7.92
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 7.92
Effect of FGF13 depletion on the H460 cell line 7.91
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 7.9
A role for ZNF598 in post-transcriptional gene regulation 7.9
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 7.88
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 7.86
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 7.86
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 7.82
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 7.74
Identification of Sin3B regulated genes during quiescence 7.72
Role of microRNAs in the interaction between Salmonella and the host cell 7.69
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 7.67
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 7.67
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 7.66
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 7.66
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 7.64
Total RNA-seq in ALL-SIL upon TLX1 knockdown 7.63
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 7.58
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 7.53
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 7.53
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 7.46
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 7.44
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 7.38
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 7.38
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 7.34
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 7.34
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 7.33
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 7.3
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 7.25
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 7.25
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 7.25
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 7.23
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 7.2
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 7.13
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 7.12
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 7.1
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 7.07
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 7.05
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 7.05
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 7.04
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 7.04
A map of gene expression in neutrophil-like cell lines 7.02
Novel Targeting of Transcription and Metabolism in Glioblastoma 6.97
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 6.9
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 6.83
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 6.79
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 6.69
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 6.58
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 6.58
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 6.58
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 6.54
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 6.54
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 6.54
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 6.52
6mer seed toxicity in viral microRNAs 6.52
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 6.52
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 6.49
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 6.36
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 6.36
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 6.32
Solid phase chemistry to covalently and reversibly capture thiolated RNA 6.27
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 6.25
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 6.23
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 6.19
Human neutrophil genome during PMA- and E. coli encounter-induced activation 6.16
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 6.16
Role of XRN2 ribonucleolytic activity in RNA metabolism 6.15
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 6.15
Identification of a LIF-responsive replication-competent human β cell 6.13
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 6.08
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 6.08
METTL3 and WTAP 6.07
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 6.04
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 6.03
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 5.99
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 5.94
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 5.87
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 5.87
Selective expression of long non-coding RNAs in a breast cancer cell progression model 5.87
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 5.86
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 5.8
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 5.8
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 5.79
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 5.72
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 5.59
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 5.56
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 5.56
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 5.54
Human cells contain natural double-stranded RNAs with potential regulatory capacity 5.53
RNA-seq of RKO cells with cTAZ KO or putback 5.52
Transcriptomic analysis of the HOTAIR-regulated genes 5.5
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 5.43
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 5.43
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 5.43
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 5.36
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 5.36
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 5.36
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 5.27
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 5.25
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 5.19
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 5.16
Human HAP1 cells before and after nutrient deprivation 5.16
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 5.1
Loss of endometrial plasticity in recurrent pregnancy loss 5.1
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 5.1
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 5.05
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 5.0
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 5.0
Measure transcript integrity using RNA-seq data 4.99
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 4.99
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 4.86
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 4.8
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 4.79
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 4.79
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 4.77
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.74
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 4.74
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 4.74
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 4.73
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 4.64
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 4.61
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 4.56
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 4.56
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 4.48
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.37
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 4.36
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 4.31
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 4.31
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 4.3
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 4.3
An siRNA screen identifies CHD4 as a target for epigenetic therapy 4.29
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 4.22
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 4.22
mRNA expression in human DAOY cells 4.21
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 4.17
FOXP2's impact on the primate transcriptome 4.01
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 4.01
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 3.94
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 3.93
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 3.92
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 3.92
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 3.89
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 3.89
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 3.83
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.83
Gene expression profile in breast cancer cells 3.83
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.79
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 3.73
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 3.69
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 3.68
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 3.66
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 3.63
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 3.58
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 3.54
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.41
Comparative Analysis of Cas9 Activators Across Multiple Species 3.39
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 3.37
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 3.24
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 3.22
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 3.21
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 3.21
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 3.0
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 2.99
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 2.99
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 2.91
Ribosome profiling upon inhibition of eIF4A 2.91
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 2.85
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 2.82
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 2.78
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.78
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.77
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.77
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.76
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 2.75
6mer seed toxicity in tumour suppressive microRNAs 2.75
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.72
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 2.71
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.68
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 2.67
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 2.66
p53 activity results in DNA replication fork processivity 2.63
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 2.62
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 2.58
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 2.56
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.54
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 2.54
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 2.54
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.49
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.43
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 2.43
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 2.42
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 2.4
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 2.21
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 1.97
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.93
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 1.88
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.88
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.83
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.82
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.76
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.75
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.75
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 1.75
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.74
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.73
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.73
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 1.69
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.69
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.67
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.64
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.62
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.55
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 1.55
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 1.51
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 1.5
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 1.5
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.49
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.49
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.48
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.44
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.4
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.35
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.35
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.34
Human Treg IL-12 stimulation 1.34
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.34
RNA sequencing with KSHV infection and enrichment for circular RNAs 1.21
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 1.14
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 1.11
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 1.09
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.04
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.99
A single-cell transcriptome atlas of the human pancreas 0.99
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 0.93
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 0.92
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.84
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.79
Determining mRNA half-lives on a transcriptome-wide scale 0.75
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 0.7
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.7
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.68
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.67
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.6
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.6
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 0.59
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 0.59
Impact on erythroid progenitor type on erythroid differntiation 0.59
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.52
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 0.46
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.44
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.41
EGR1-controlled transcriptome of T HESCs 0.32
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.32
Human Tfh cell RNA bulk sequencing 0.31
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.3
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.3
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.23
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 0.2
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 0.17
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.12
Gene expression profiling of KSHV-infected periodontal ligament cells 0.1
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.06
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.05
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.05
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.04
SF3B1 Degron knockdown RNA-seq 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation